PubMed

Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.

Ramanathan RK, Rothenberg ML, de Gramont A, Tournigand C, Goldberg RM, Gupta S, André T.

Ann Oncol. 2009 Nov 3. [Epub ahead of print]PMID: 19887466 [PubMed - as supplied by publisher]Related articles

Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904.

Kulke MH, Tempero MA, Niedzwiecki D, Hollis DR, Kindler HL, Cusnir M, Enzinger PC, Gorsch SM, Goldberg RM, Mayer RJ.

J Clin Oncol. 2009 Nov 20;27(33):5506-5512. Epub 2009 Oct 26.PMID: 19858396 [PubMed - as supplied by publisher]Related articles

NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial.

Goldberg RM, Sargent DJ, Morton RF, Green E, Sanoff HK, McLeod H, Buckner J.

Oncologist. 2009 Oct;14(10):970-8. Epub 2009 Oct 14.PMID: 19828593 [PubMed - in process]Related articles

Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.

Dy GK, Hobday TJ, Nelson G, Windschitl HE, O'Connell MJ, Alberts SR, Goldberg RM, Nikcevich DA, Sargent DJ.

Clin Colorectal Cancer. 2009 Apr;8(2):88-93. Review.PMID: 19739269 [PubMed - indexed for MEDLINE]Related articles

Colorectal cancer: Irinotecan therapy-following a trail of breadcrumbs?

Goldberg RM, O'Neil BH.

Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):507-9.PMID: 19713983 [PubMed - indexed for MEDLINE]Related articles

Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial.

Sanoff HK, Sargent DJ, Green EM, McLeod HL, Goldberg RM.

J Clin Oncol. 2009 Sep 1;27(25):4109-15. Epub 2009 Jul 27.PMID: 19636001 [PubMed - indexed for MEDLINE]Related articles

Cetuximab, chemotherapy and KRAS status in mCRC.

Gill S, Goldberg RM.

Nat Rev Clin Oncol. 2009 Jul;6(7):379-80. No abstract available. PMID: 19561631 [PubMed - indexed for MEDLINE]Related articles

A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher.

Shah U, O'Neil B, Allen J, Goldberg RM, Bernard S, Moore D, Venook AP, Morse MM.

Gastrointest Cancer Res. 2009 Mar;3(2):45-8.PMID: 19461906 [PubMed - in process]Related articlesFree article

Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a north central cancer treatment group review of 3811 patients, n0144.

Dy GK, Hobday TJ, Nelson G, Windschitl HE, O'Connell MJ, Alberts SR, Goldberg RM, Nikcevich DA, Sargent DJ.

Clin Colorectal Cancer. 2009 Mar;8(2):88-93.PMID: 19423501 [PubMed - as supplied by publisher]Related articles

Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation.

Hillman SL, An MW, O'Connell MJ, Goldberg RM, Schaefer P, Buckner JC, Sargent DJ.

J Clin Oncol. 2009 Jul 1;27(19):3205-10. Epub 2009 May 4.PMID: 19414682 [PubMed - indexed for MEDLINE]Related articles

Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.

Allegra CJ, Yothers G, O'Connell MJ, Sharif S, Colangelo LH, Lopa SH, Petrelli NJ, Goldberg RM, Atkins JN, Seay TE, Fehrenbacher L, O'Reilly S, Chu L, Azar CA, Wolmark N.

J Clin Oncol. 2009 Jul 10;27(20):3385-90. Epub 2009 May 4.PMID: 19414665 [PubMed - indexed for MEDLINE]Related articles

Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.

Cmelak AJ, Lordick F, Borner M, Goldberg RM, Saif MW.

Oncology (Williston Park). 2009 Feb;23(2 Suppl 1):18-25. Review.PMID: 19385163 [PubMed - indexed for MEDLINE]Related articles

Infusion reactions associated with monoclonal antibodies in patients with solid tumors. Introduction.

Cmelak AJ, Goldberg RM.

Oncology (Williston Park). 2009 Feb;23(2 Suppl 1):5-6. No abstract available. PMID: 19385160 [PubMed - indexed for MEDLINE]Related articles

Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.

Kim GP, Sargent DJ, Mahoney MR, Rowland KM Jr, Philip PA, Mitchell E, Mathews AP, Fitch TR, Goldberg RM, Alberts SR, Pitot HC.

J Clin Oncol. 2009 Jun 10;27(17):2848-54. Epub 2009 Apr 20.PMID: 19380443 [PubMed - indexed for MEDLINE]Related articles

Accomplishments in 2007 in the treatment of advanced colorectal cancer.

Goldberg RM, Carrato A.

Gastrointest Cancer Res. 2008 May;2(3 Suppl):S19-24.PMID: 19352463 [PubMed - in process]Related articlesFree article

Cost implications of new treatments for advanced colorectal cancer.

Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR.

Cancer. 2009 May 15;115(10):2081-91.PMID: 19309745 [PubMed - indexed for MEDLINE]Related articles

p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.

Bertagnolli MM, Warren RS, Niedzwiecki D, Mueller E, Compton CC, Redston M, Hall M, Hahn HP, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Loda M.

Clin Cancer Res. 2009 Mar 15;15(6):2116-22. Epub 2009 Mar 10.PMID: 19276255 [PubMed - indexed for MEDLINE]Related articles

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M.

J Clin Oncol. 2009 Apr 10;27(11):1814-21. Epub 2009 Mar 9.PMID: 19273709 [PubMed - indexed for MEDLINE]Related articles

As Federal Funding for Cancer is Cut, Researchers Struggle.

Goldberg RM.

Gastrointest Cancer Res. 2008 May;2(3):165. No abstract available. PMID: 19259296 [PubMed - in process]Related articlesFree article

Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.

Sargent DJ, Köhne CH, Sanoff HK, Bot BM, Seymour MT, de Gramont A, Porschen R, Saltz LB, Rougier P, Tournigand C, Douillard JY, Stephens RJ, Grothey A, Goldberg RM.

J Clin Oncol. 2009 Apr 20;27(12):1948-55. Epub 2009 Mar 2. Erratum in: J Clin Oncol. 2009 Jul 10;27(20):3410-1. PMID: 19255311 [PubMed - indexed for MEDLINE]Related articles

Commentary: Disclosure in oncology -- to whom does the truth belong?

Wood WA, McCabe MS, Goldberg RM.

Oncologist. 2009 Jan;14(1):77-82. Epub 2009 Jan 15.PMID: 19147691 [PubMed - indexed for MEDLINE]Related articles

Platinum neurotoxicity pharmacogenetics.

McWhinney SR, Goldberg RM, McLeod HL.

Mol Cancer Ther. 2009 Jan;8(1):10-6. Review.PMID: 19139108 [PubMed - indexed for MEDLINE]Related articles

First-line therapeutic strategies in metastatic colorectal cancer.

Davies JM, Goldberg RM.

Oncology (Williston Park). 2008 Nov 30;22(13):1470-9. Review.PMID: 19133603 [PubMed - indexed for MEDLINE]Related articles

Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.

Fuchs CS, Goldberg RM, Sargent DJ, Meyerhardt JA, Wolpin BM, Green EM, Pitot HC, Pollak M.

Clin Cancer Res. 2008 Dec 15;14(24):8263-9. Epub 2008 Dec 10.PMID: 19073970 [PubMed - indexed for MEDLINE]Related articles

What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?

O'Neil BH, Goldberg RM.

Nat Clin Pract Oncol. 2009 Jan;6(1):14-6. Epub 2008 Nov 11. No abstract available. PMID: 19002130 [PubMed - indexed for MEDLINE]Related articles

Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.

Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Goldberg RM.

J Clin Oncol. 2008 Dec 10;26(35):5721-7. Epub 2008 Nov 10.PMID: 19001325 [PubMed - indexed for MEDLINE]Related articles

Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.

O'Neil BH, Goldberg RM.

Oncologist. 2008 Oct;13(10):1074-83. Epub 2008 Oct 15. Review.PMID: 18922828 [PubMed - indexed for MEDLINE]Related articlesFree article

Sequential versus combination therapy in the treatment of patients with advanced colorectal cancer.

Shah U, Goldberg RM.

Clin Colorectal Cancer. 2008 Sep;7(5):315-20. Review.PMID: 18794063 [PubMed - indexed for MEDLINE]Related articles

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, Goldberg RM, Warren RS, Bertagnolli M, Fuchs CS.

JAMA. 2008 Jun 4;299(21):2515-23.PMID: 18523220 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).

Meropol NJ, Niedzwiecki D, Shank B, Colacchio TA, Ellerton J, Valone F, Budinger S, Day JM, Hopkins J, Tepper J, Goldberg RM, Mayer RJ.

J Clin Oncol. 2008 Jul 1;26(19):3229-34. Epub 2008 May 19.PMID: 18490648 [PubMed - indexed for MEDLINE]Related articles

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG, Sargent DJ.

J Clin Oncol. 2008 May 10;26(14):2336-41.PMID: 18467725 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.

Stinchcombe TE, Socinski MA, Lee CB, Hayes DN, Moore DT, Goldberg RM, Dees EC.

J Thorac Oncol. 2008 May;3(5):521-6.PMID: 18449006 [PubMed - indexed for MEDLINE]Related articles

Chemotherapy in elderly patients with colorectal cancer.

Köhne CH, Folprecht G, Goldberg RM, Mitry E, Rougier P.

Oncologist. 2008 Apr;13(4):390-402.PMID: 18448553 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.

Caudle AS, Kim HJ, Tepper JE, O'Neil BH, Lange LA, Goldberg RM, Bernard SA, Calvo BF, Meyers MO.

Ann Surg Oncol. 2008 Jul;15(7):1931-6. Epub 2008 Apr 17.PMID: 18418656 [PubMed - indexed for MEDLINE]Related articles

Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.

Grothey A, Hedrick EE, Mass RD, Sarkar S, Suzuki S, Ramanathan RK, Hurwitz HI, Goldberg RM, Sargent DJ.

J Clin Oncol. 2008 Jan 10;26(2):183-9.PMID: 18182660 [PubMed - indexed for MEDLINE]Related articles

Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?

Yen-Revollo JL, Goldberg RM, McLeod HL.

Clin Cancer Res. 2008 Jan 1;14(1):8-13. Review.PMID: 18172246 [PubMed - indexed for MEDLINE]Related articlesFree article

Dealing With Discordance: Managing a Case Where the Patient Looks Better and the CT Scan Looks Worse.

Shah U, Goldberg RM.

Gastrointest Cancer Res. 2008 Jan;2(1):45-6. No abstract available. PMID: 19259322 [PubMed - in process]Related articlesFree article

A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patients.

Sanoff HK, Goldberg RM, Pignone MP.

Clin Colorectal Cancer. 2007 Nov;6(10):700-9. Review.PMID: 18039423 [PubMed - indexed for MEDLINE]Related articles

Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas.

O'Neil BH, Bůzková P, Farrah H, Kashatus D, Sanoff H, Goldberg RM, Baldwin AS, Funkhouser WK.

Oncology. 2007;72(1-2):97-104. Epub 2007 Nov 15.PMID: 18025803 [PubMed - indexed for MEDLINE]Related articles

A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.

Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ.

Ann Surg Oncol. 2008 Jan;15(1):158-64. Epub 2007 Nov 16. Erratum in: Ann Surg Oncol. 2009 Aug;16(8):2381. Mayer, Robert J [added]. PMID: 18008108 [PubMed - indexed for MEDLINE]Related articles

Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology.

Goldberg RM, Marshall JL, Ajani JA, Philip PA, O'Reilly EM, Venook AP.

Gastrointest Cancer Res. 2007 Nov;1(6 Suppl):S13-6. No abstract available. PMID: 19330058 [PubMed - in process]Related articlesFree article

Section I: essentials of ensuring excellence in cancer care.

Goldberg RM, Marshall JL, Kachnic LA, Venook AP.

Gastrointest Cancer Res. 2007 Nov;1(6 Suppl):S1-3. No abstract available. PMID: 19330057 [PubMed - in process]Related articlesFree article

Colorectal cancer treatment in older patients.

Sanoff HK, Goldberg RM.

Gastrointest Cancer Res. 2007 Nov;1(6):248-53.PMID: 19262903 [PubMed - in process]Related articlesFree article

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Kerr D, Green E, Wieand HS, Goldberg RM, de Gramont A; ACCENT Group.

J Clin Oncol. 2007 Oct 10;25(29):4569-74. Epub 2007 Sep 17.PMID: 17876008 [PubMed - indexed for MEDLINE]Related articles

UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, McLeod HL.

J Natl Cancer Inst. 2007 Sep 5;99(17):1290-5. Epub 2007 Aug 28.PMID: 17728214 [PubMed - indexed for MEDLINE]Related articlesFree article

High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history.

O'Neil BH, Allen R, Spigel DR, Stinchcombe TE, Moore DT, Berlin JD, Goldberg RM.

J Clin Oncol. 2007 Aug 20;25(24):3644-8.PMID: 17704414 [PubMed - indexed for MEDLINE]Related articles

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

Dy GK, Krook JE, Green EM, Sargent DJ, Delaunoit T, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pockaj BA, Sticca RP, Alberts SR, Pitot HC 4th, Goldberg RM; Intergroup N9741.

J Clin Oncol. 2007 Aug 10;25(23):3469-74. Erratum in: J Clin Oncol. 2007 Nov 20;25(33):5339. PMID: 17687151 [PubMed - indexed for MEDLINE]Related articles

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Saltz LB, Niedzwiecki D, Hollis D, Goldberg RM, Hantel A, Thomas JP, Fields AL, Mayer RJ.

J Clin Oncol. 2007 Aug 10;25(23):3456-61.PMID: 17687149 [PubMed - indexed for MEDLINE]Related articles

Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.

Alberts SR, Kim GP, Mahoney MR, Gornet MK, Rubin J, Ames M, Goetz MP, Weinshilboum RM, Nicol SJ, Goldberg RM.

Clin Colorectal Cancer. 2007 Jul;6(8):572-7.PMID: 17681103 [PubMed - indexed for MEDLINE]Related articles

Which strategies will lead to progress in the management of colorectal cancer?

Goldberg RM.

Gastrointest Cancer Res. 2007 Jul;1(4 Suppl 2):S33-6.PMID: 19360145 [PubMed - in process]Related articlesFree article